Ameriprise’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-119,280
Closed -$686K 3667
2018
Q4
$686K Sell
119,280
-4,222
-3% -$24.3K ﹤0.01% 3080
2018
Q3
$1.68M Sell
123,502
-123,146
-50% -$1.67M ﹤0.01% 2871
2018
Q2
$2.93M Buy
246,648
+24,661
+11% +$293K ﹤0.01% 2560
2018
Q1
$2.49M Buy
+221,987
New +$2.49M ﹤0.01% 2598